CIK: 1224663 - Address: 3471 River Hills Drive, Cincinnati, OH 45244
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1180346133410
S%wins8825253801331

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/20/14 09:32
11/18/14
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOEVP,CFOS.d-10916.205-7-5133D-13-31-21-18-5-12-50035201625
12/17/12 11:45
12/13/12
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOEVP,CFOS.dm-41719.844-21-16114D-9116101-3-2-3336151131
12/15/10 14:24
12/13/10
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOEVP,CFOS-53023.574-23-1999D3133525274002-3-112-18
7/26/07 13:21
7/24/07
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOVP,CFOS.d-42622.965-19-2265D1446720144522-1-211234314
1/26/07 16:49
1/24/07
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOVP,CFOS.m-43729.109-15-2544D20216412518199401-641869
1/9/04 11:51
1/5/04
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOVP,CFOS.ad-556.301-9-2921D97691586332-1159-7666
1/7/04 14:40
1/5/04
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOVP,CFOS.d-556.301-9-2921D85621568104047-1266
9/10/03 16:51
9/8/03
VIVOMeridian Bioscience IncOHHealthDiagnIn Vitro & In Vivo DiagnosticLueke MelissaOHOVP,CFOS-5310.501-5-408D1107837140-5-2-20-417715

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact